Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides…
FDA In Brief: New analysis highlights link between generic drug competition and lower drug prices, underscores importance of FDA efforts…
FDA Updates List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic — Read on s2027422842.t.en25.com/e/es
Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides…
FDA updates list of inquiries from prospective generic drug applicants about RLD access — Read on s2027422842.t.en25.com/e/es
The FDA is issuing an update regarding the ongoing efforts to resolve safety issues with ARB medications. — Read on…
The Federal Food, Drug, and Cosmetic Act (FD&C Act or statute), as amended by the Generic Drug User Fee Amendments…